Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Itolizumab Safety and Efficacy Study in Covid 19
26/03/2021
Registered
Itolizumab-Plasmapheresis in patients with COVID-19
30/06/2021
Registered
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II
22/04/2016
Registered
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.
2010-12-29
Registered
NeuroEPO in mild-moderate Alzheimer's disease
20/09/2022
Registered
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant
22/09/2022
Registered
NeuroEPO in patients with Mild-Moderate Alzheimer's disease
01/02/2017
Registered
NeuroEPO in patients with Parkinson disease stage II-III
01/02/2017
Registered
NeuroEPO in stroke
02/08/2018
Registered
NeuroEPO-Ataxia-Adults-Phase III
19/11/2020
Registered outdated
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer
12/10/2016
Registered
NGcGM3/VSSP in Metastatic melanoma
07/12/2016
Registered
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer
28/11/2016
Registered
NGcGM3/VSSP in small cell lung cancer
07/12/2016
Registered outdated
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.
2010-12-17
Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II
2010-12-17
Registered
Nimotuzumab cold kit for the immunodiagnosis of solid tumors
05/10/2018
Registered
Nimotuzumab in COVID-19
21/05/2021
Registered
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)
28/12/2018
Registered outdated
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS)
03/03/2023
Registered
« first
‹ previous
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform